CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
What Is Market Breadth In Stock Markets explains breadth concepts and how they signal overall market health and leadership.
27,567 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A leading analyst signals more upside for CVS Health as Medicare-related momentum builds. Learn the key drivers, risk...
A recent insider sale of 5,595 Hilton Grand Vacations shares has investors asking what it means for the stock. This g...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
Palo Alto Networks’ stock fell after the latest earnings, as traders weighed a murky near-term outlook against the co...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
Memory demand tied to AI and data centers has Micron at a pivotal moment. This guide breaks down whether micron stock...
Rivian just raised its vehicle guidance to 70,000 units while a company director sold shares. This article breaks dow...
When markets wobble, patient investors can unlock real opportunities. This guide breaks down a clear process to spot ...
A fresh AI marketing venture is tying Reg A+ funding to an $0.85 share price, aiming to deliver rapid ROI for major b...
NVIDIA’s forecast for Q1 2027 signals massive AI infrastructure demand, while Apple charts a different path. The clas...
Berkshire Hathaway reports a record cash and Treasury position, signaling Buffett’s readiness to act when markets dis...